13th Pharmacovigilance 2017 – “Ensuring safer drugs to market by analyzing latest developments in pharmacovigilance, drug safety and risk management”
13th Pharmacovigilance 2017
“Ensuring safer drugs to market by analyzing latest developments in pharmacovigilance, drug safety and risk management”
27th & 28th September 2017, Holiday Inn Chicago O’Hare, USA
13th Pharmacovigilance 2017 will bring together top pharmaceutical, biotechnology and regulatory representatives under one roof that will address the key issues of the industry. The entire program will cover the detection, analysis and prevention of adverse drug reactions. It will be studied with the help of case studies and industry experiences. This conference will help the drug safety representatives from the pharmaceutical industry and academic and quality research organizations who wish to understand how to avoid common deficiencies in inspections by learning from the experiences of others; to gain a greater understanding of new and existing pv requirements, and to improve their organizations’ compliance with pv requirements. Also it can help you control your product’s lifecycle, your patient’s trust, and your revenue.
CONFERENCE BOOKING DETAILS:
E-mail: kavitha@virtueinsight.co.in or TEL: +44 2036120886
Introductory Offer (3 delegate places for the price of 2) – A huge saving of £900 – (Limited seats left)
Early Bird Registration until 6th Aug 2017 – £900 per delegate
Standard Registration from 7th Aug 2017 – £1100 per delegate
Conference Sponsor & Exhibition Stall and paid Speaker Slot are also available.
13th Pharmacovigilance conference will provide an important platform for pharmacovigilance stakeholders to discuss and share best practices in expediting pharmacovigilance development.
To learn more visit:
http://www.virtueinsight.com/pharma/13th-Pharmacovigilance-2017/
For more Queries & Details contact
Kavitha
E: Kavitha@virtueinsight.co.in
P: +91 44 2036120886
